Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Maintaining restraint in the face of danger

02.04.2012
A central regulator of the inflammatory response shows signs as an appealing target for therapies against autoimmune disease
Some bacterial infections trigger the formation of structures known as granulomas, which essentially quarantine compromised cells. “Infected macrophages get surrounded by other immune cells, such as T cells and neutrophils,” explains Takashi Tanaka of the RIKEN Research Center for Allergy and Immunology in Yokohama. “This serves to wall off pathogens that resist destruction and limits their infection within a restricted area.”

This response is generally beneficial but can lead to a harmful overreaction, especially in patients with autoimmune conditions, where the inflammatory response is not properly regulated. In collaboration with Tadashi Matsuda of Hokkaido University, Tanaka’s group has now revealed a key regulatory checkpoint in the granuloma formation process, which might ultimately inform the development of more effective immunomodulatory drugs.

Historically, a subset of the immune system’s helper T cells, called TH1 cells, has been associated with autoimmunity. Previous research by Tanaka demonstrated that a protein called PDLIM2 helps restrict production of these cells. More recently, other researchers identified a population of helper T cells called TH17 cells that also contribute to this process, although their role was unclear, so Tanaka sought to determine whether PDLIM2 regulates these cells as well.

His team found that mice lacking the gene encoding PDLIM2 formed many more granulomas in response to infection with Propionibacterium acnes bacteria, and that this process was dependent on the action of TH17 cells. In fact, the researchers showed that PDLIM2 directly inhibits the differentiation of CD4+ T cells into TH17 cells, as was previously demonstrated with TH1 development. This protein works by marking other proteins for rapid degradation. Tanaka and colleagues learned that PDLIM2 specifically promotes the destruction of STAT3, a signaling protein that switches on genes responsible for TH17 development. Without PDLIM2 constraining the formation of these pro-inflammatory cells, the immune response has the potential to spiral out of control.

This protein therefore appears to be a key safeguard against autoimmunity. “Recent studies suggest that TH1 and TH17 cell subsets are not mutually exclusive, but cooperatively induce inflammatory responses,” says Tanaka. “Our work demonstrates that PDLIM2 can negatively regulate the development of both cells, and thus represents a useful new target for the treatment of human autoimmune and inflammatory diseases.” Tanaka and colleagues now hope to better understand this protein’s function by clarifying the regulatory factors that act upstream and downstream of PDLIM2, and by clarifying how this system influences other inflammatory processes, such as those observed in cases of asthma or during wound healing.

The corresponding author for this highlight is based at the Research Unit for Inflammatory Regulation, RIKEN Research Center for Allergy and Immunology

gro-pr | Research asia research news
Further information:
http://www.riken.jp
http://www.researchsea.com

More articles from Health and Medicine:

nachricht Penn vet research identifies new target for taming Ebola
12.01.2017 | University of Pennsylvania

nachricht The strange double life of Dab2
10.01.2017 | University of Miami Miller School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

Im Focus: How to inflate a hardened concrete shell with a weight of 80 t

At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).

Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...

Im Focus: Bacterial Pac Man molecule snaps at sugar

Many pathogens use certain sugar compounds from their host to help conceal themselves against the immune system. Scientists at the University of Bonn have now, in cooperation with researchers at the University of York in the United Kingdom, analyzed the dynamics of a bacterial molecule that is involved in this process. They demonstrate that the protein grabs onto the sugar molecule with a Pac Man-like chewing motion and holds it until it can be used. Their results could help design therapeutics that could make the protein poorer at grabbing and holding and hence compromise the pathogen in the host. The study has now been published in “Biophysical Journal”.

The cells of the mouth, nose and intestinal mucosa produce large quantities of a chemical called sialic acid. Many bacteria possess a special transport system...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

Nothing will happen without batteries making it happen!

05.01.2017 | Event News

 
Latest News

Water - as the underlying driver of the Earth’s carbon cycle

17.01.2017 | Earth Sciences

Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

17.01.2017 | Materials Sciences

Smart homes will “LISTEN” to your voice

17.01.2017 | Architecture and Construction

VideoLinks
B2B-VideoLinks
More VideoLinks >>>